14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $0.0060 $169.56 Wednesday, 30th Aug 2023 TCRR stock ended at $1.48. During the day the stock fluctuated 0% from a day low at $1.48 to a day high of $1.48.
90 days $113.65 $133.77
52 weeks $171.20 $133.77

Historical TCR2 Therapeutics Inc. prices

Date Open High Low Close Volume
Apr 06, 2023 $1.44 $1.52 $1.42 $1.47 341 597
Apr 05, 2023 $1.44 $1.46 $1.40 $1.43 143 444
Apr 04, 2023 $1.51 $1.53 $1.42 $1.45 179 415
Apr 03, 2023 $1.49 $1.54 $1.47 $1.50 486 136
Mar 31, 2023 $1.45 $1.50 $1.45 $1.50 159 975
Mar 30, 2023 $1.45 $1.50 $1.44 $1.44 98 389
Mar 29, 2023 $1.46 $1.49 $1.43 $1.45 90 735
Mar 28, 2023 $1.48 $1.50 $1.45 $1.46 166 101
Mar 27, 2023 $1.50 $1.52 $1.45 $1.51 126 283
Mar 24, 2023 $1.36 $1.52 $1.36 $1.50 241 351
Mar 23, 2023 $1.52 $1.52 $1.34 $1.42 332 155
Mar 22, 2023 $1.52 $1.57 $1.46 $1.47 169 372
Mar 21, 2023 $1.44 $1.55 $1.41 $1.54 312 615
Mar 20, 2023 $1.47 $1.50 $1.43 $1.45 237 678
Mar 17, 2023 $1.51 $1.54 $1.44 $1.46 415 163
Mar 16, 2023 $1.48 $1.65 $1.46 $1.56 308 196
Mar 15, 2023 $1.51 $1.53 $1.44 $1.49 128 079
Mar 14, 2023 $1.45 $1.54 $1.43 $1.51 312 185
Mar 13, 2023 $1.40 $1.48 $1.35 $1.43 340 180
Mar 10, 2023 $1.53 $1.54 $1.38 $1.43 731 019
Mar 09, 2023 $1.56 $1.61 $1.51 $1.56 584 548
Mar 08, 2023 $1.62 $1.64 $1.54 $1.55 1 021 400
Mar 07, 2023 $1.57 $1.85 $1.55 $1.60 2 654 040
Mar 06, 2023 $1.55 $1.78 $1.44 $1.62 19 782 239
Mar 03, 2023 $1.20 $1.21 $1.15 $1.21 69 200
Click to get the best stock tips daily for free!

About TCR2 Therapeutics Inc.

TCR2 Therapeutics. TCR2 Therapeutics Inc., a clinical-stage immunotherapy company, focuses on developing novel T cell receptor (TCR) therapies for patients suffering from cancer. The company's lead product candidates include gavo-cel, a mono TCR Fusion Construct T cells (TRuC-T cells) targeting mesothelin positive solid tumors, which is in phase I/II clinical trial for the treatment of non-small cell lung cancer (NSCLC), ovarian cancer, malignant pleural/peritoneal... TCRR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT